α1-adrenoreceptor stimulation causes vascular smooth muscle cell hypertrophy: A possible role for isoprenoid intermediates

European Journal of Pharmacology

Volumn 347, Issue 1, 1998, Pages 125-130

  Nishio, Eisuke ^a   Kanda, Yasunari ^a   Watanabe, Yasuhiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

1 Adrenoreceptor; Famesol; Hypertrophy; Lovastatin; Smooth muscle cell

Indexed keywords

FARNESOL; MEVINOLIN; PHENYLEPHRINE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CARBON; CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LEUCINE; MEVALONIC ACID; TRANSFERASE;

ALPHA ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ARTICLE; DOSE RESPONSE; DRUG EFFECT; MUSCLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL COUNT; CELL CULTURE; DRUG ANTAGONISM; DRUG INTERACTION; HYPERTROPHY; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTEIN PROCESSING; THORACIC AORTA; ULTRASTRUCTURE;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; ANTICHOLESTEREMIC AGENTS; AORTA, THORACIC; CARBON RADIOISOTOPES; CELL COUNT; CELLS, CULTURED; CHOLESTEROL; DRUG INTERACTIONS; FARNESOL; HYPERTROPHY; LEUCINE; LOVASTATIN; MEVALONIC ACID; MUSCLE, SMOOTH, VASCULAR; PHENYLEPHRINE; PROTEIN ISOPRENYLATION; RATS; RECEPTORS, ADRENERGIC, ALPHA-1; TRANSFERASES;

EID: 0032540006     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00083-1     Document Type: Article

References (27)

1. Bruscalupi G., Castellano F., Sacco S., Trentalance A. Prenylated proteins in regenerating rat liver. Biochem. Biophys. Res. Commun. 200:1994;1713-1720.
2. ras is modified by a farnesyl isoprenoid. Proc. Natl. Acad. Sci. USA. 86:1989;8323-8327.
3. Dan N., Middleton R.B., Lehrman M.A. Hamster UDP-N-acetylglucosamine: dolichol-P N-acetylglucosamine-1-P-transferase has multiple transmembrane spans and a critical cytosolic loop. J. Biol. Chem. 271:1996;30717-30724.
4. Duggan D.E., Chen I.W., Bayne W.F., Halpin R.A., Duncan C.A., Schwattz M.S., Stubbs R.J., Vickers S. The physiological disposition of lovastatin. Drug Metab. Dispos. 17:1989;166-173.
5. Fairbanks K.P., Witte L.D., Goodman D.S. Relationship between mevalonate and mitogenesis in human fibroblasts stimulated with platelet-derived growth factor. J. Biol. Chem. 259:1984;1546-1551.
6. Geisterfer A.A., Peach M.J., Owens G.K. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62:1988;749-756.
7. Gellman J., Ezekowitz M.D., Sarembock I.J., Azrin M.A., Nochomowitz L.E., Lerner E., Haudenschild C.C. Effect of lovastatin on intimal hyperplasia after balloon angioplasty: a study in an atherosclerotic hypercholesterolemic rabbit. J. Am. Coll. Cardiol. 17:1991;251-259.
8. Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature. 343:1990;425-430.
9. Guiteras V.P., Bourassa M.G., David P.R., Bonan R., Crepeau J., Dyrda I., Lesperance J. Restenosis after successful percutaneous transluminal coronary angioplasty: the Montral Heart Institute experience. Am. J. Cardiol. 60:1987;50B-55B.
10. Houssier C., Grosjean H. Temperature jump relaxation studies on the interactions between transfer RNAs with complementary anticodons. The effect of modified bases adjacent to the anticodon triplet. J. Biomol. Struct. Dyn. 3:1985;387-408.
11. Krukemyer J.J., Talbert R.L. Lovastatin: a new cholesterol-lowering agent. Pharmacotherapy. 7:1987;198-210.
12. Leimgruber P.P., Roubin G.S., Hollman J., Cotsonis G.A., Meier B., Douglas J.S., King S.J., Gruentzig A.R. Restenosis after successful coronary angioplasty in patient with single-vessel disease. Circulation. 73:1986;710-717.
13. Mumby S.M., Casy P.J., Gilman A.G., Gutowski S., Sternweis P.C. G protein gamma subunits contain a 20-carbon isoprenoid. Proc. Natl. Acad. Sci. USA. 87:1990;5873-5877.
14. Munro E., Patel M., Chan P., Betterige L., Clunn G., Gallagher K., Hughes A., Schachter M., Wolfe J., Sever P. Inhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates of cholesterol synthesis. Eur. J. Clin. Invest. 24:1994;766-772.
15. Nishio E., Arimura S., Watanabe Y. Oxidized LDL induces apoptosis in cultured smooth muscle cells: a possible role for 7-ketocholesterol. Biochem. Biophys. Res. Commun. 223:1996;413-418.
16. Nishio E., Tomiyama K., Nakata H., Watanabe Y. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor impairs cell differentiation in cultured adipogenic cells (3T3-L1). Eur. J. Parmacol. 301:1996;203-206.
17. 1-adrenoreceptor-induced smooth muscle cell proliferation and migration. Brit. J. Pharmacol. 121:1997;665-670.
18. Noveral J.P., Grunstein M.M. Adrenergic receptor-mediated regulation of cultured rabbit airway smooth muscle cell proliferation. Am. J. Physiol. 267:1994;L291-299.
19. Olivetti G., Melissari M., Marchetti G., Anversa P. Quantitative structural changes of the rat thoracic aorta in early spontaneous hypertension. Tissue composition, and hypertrophy and hyperplasia of smooth muscle cells. Circ. Res. 51:1982;19-26.
20. Owens G.K. Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension. 9:1987;178-187.
21. Owens G.K., Schwartz S.M. Vascular smooth muscle cell hypertrophy and hyperploidy in the Goldblatt hypertensive rat. Circ. Res. 53:1983;491-501.
22. Owens G.K., Reidy M.A. Hyperplastic growth response of vascular smooth muscle cells following induction of acute hypertension in rats by aortic coarctation. Circ. Res. 57:1985;695-705.
23. Robinson K.M., Lemire B.D. Covalent attachment of FAD to the yeast succinate dehydrogenase flavoprotein requires import into mitochondria, presequence removal, and folding. J. Biol. Chem. 271:1996;4055-4060.
24. Santos E., Nebreda A.R. Structural and functional properties of ras proteins. FASEB J. 3:1989;2151-2163.
25. Schmidt R.A., Glomset J.A., Wight T.N., Habenicht A.J.R., Ross R. A study of the influence of mevalonic acid and its metabolites on the morphology of Swiss 3T3 cells. J. Cell Biol. 95:1982;144-153.
26. Siperstein M.D. Role of cholesterogenesis and isoprenoid synthesis in DNA replication and cell growth. J. Lipid Res. 25:1984;1462-1468.
27. Yamori Y., Tarazi R.C., Ooshima A. Effect of beta-receptor-blocking agents on cardiovascular structural changes in spontaneous and noradrenaline-induced hypertension in rats. Clin. Sci. 59:1980;457s-460s.